Meng et al. have found that IRAK4 is extremely upregulated in nasopharyngeal carcinoma cells, and S100A14 could inhibit NF-κB pathway to impede the progression of the cancer via targeting IRAK4 [23]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.